Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M al-Dhalimy

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Nature Genetics|March 1, 1996
Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type IK Overturf, M Al-Dhalimy, R Tanguay, et al.
Genes & Development|December 1, 1993
Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino miceM Grompe, M al-Dhalimy, M Finegold, et al.
Human Gene Therapy|March 20, 1997
Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type IK Overturf, M al-Dhalimy, C N Ou, et al.
Nature Genetics|August 1, 1995
Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type IM Grompe, S Lindstedt, M al-Dhalimy, et al.
Nature Medicine|November 4, 2000
Purified hematopoietic stem cells can differentiate into hepatocytes in vivoE Lagasse, H Connors, M Al-Dhalimy, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Nature Genetics|March 1, 1996
Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type IK Overturf, M Al-Dhalimy, R Tanguay, et al.
Genes & Development|December 1, 1993
Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino miceM Grompe, M al-Dhalimy, M Finegold, et al.
Human Gene Therapy|March 20, 1997
Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type IK Overturf, M al-Dhalimy, C N Ou, et al.
Nature Genetics|August 1, 1995
Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type IM Grompe, S Lindstedt, M al-Dhalimy, et al.
Nature Medicine|November 4, 2000
Purified hematopoietic stem cells can differentiate into hepatocytes in vivoE Lagasse, H Connors, M Al-Dhalimy, et al.
Pageof 2